Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Drug Delivery Firm Acusphere Raises $20M In Eighth Round

April 22, 2003

By Aaron Lorenzo

Drug Delivery Firm Acusphere Raises $20M In Eighth Round

April 22, 2003

By Aaron Lorenzo

Protein Mechanics Pursues In Silico Drug Development

April 21, 2003

By Aaron Lorenzo

Protein Pathways Lands Merck In First Technology Partnership

April 21, 2003

By Aaron Lorenzo

Protein Pathways Lands Merck In First Technology Partnership

April 21, 2003

By Aaron Lorenzo

Protein Mechanics Pursues In Silico Drug Development

April 21, 2003

By Aaron Lorenzo

Biogen Beats Earnings Estimates On Steady Sales, Amevive Growth

April 18, 2003

By Aaron Lorenzo

Biogen Beats Earnings Estimates On Steady Sales, Amevive Growth

April 18, 2003

By Aaron Lorenzo

CancerVax Resuming Phase III Trials Of Canvaxin In Melanoma

April 16, 2003

By Aaron Lorenzo

CancerVax Resuming Phase III Trials Of Canvaxin In Melanoma

April 16, 2003

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.